Popular Articles

New Promising Alzheimer's Disease Treatment: Mount Sinai
Researchers at Mount Sinai School of Medicine have found that a compound called NIC5-15, might be a safe and effective treatment to stabilize cognitive performance in patients with mild to moderate Alzheimer"s disease. The two investigators, Giulio Maria Pasinetti, M.D., Ph.D. , and Hillel Grossman, M.D., presented Phase IIA preliminary clinical findings at the Alzheimer"s Association 2009 International Conference on Alzheimer"s Disease (ICAD) in Vienna on Sunday, July 12.
generic viagra online
Sanomedics Pioneers Home Health Monitoring On Two Continents
Incredible new digital technology, rising healthcare costs, world-wide pandemics, a move toward more personal responsibility and shifting demographics - all of these factors are leading to dramatic changes in the way healthcare services are delivered. Among the most dramatic changes introduces high-tech healthcare into the home, and Sanomedics is in the forefront of this new societal trend.
News of the day
The Alliance For The Advancement Of Adult Stem Cell Therapy And Research Announces Successful Treatment Of End-Stage Heart Disease With Stem Cells
Zannos Grekos, MD, Associate Clinical Professor at Nova Southeastern University, has announced six month follow-up results for a patient treated with adult stem cells in a clinical study of idiopathic dilated cardiomyopathy. The clinical study is a collaborative effort among physicians at Regenocyte Therapeutic, an American stem cell therapy clinic; researchers and scientists from Theravitae, a biotechnology company from Israel; and physicians from the American Institute for Regenerative Medicine, Dominican Republic.
Medical Devices

Visit To The Doctor: The Supply Of Additional Private Services Is Increasing

Panel physicians are increasingly offering individual health services (IHS) to patients with statutory health insurance. This is documented by Susanne Richter et al. of the Department of Social Medicine, Lubeck University, in the new edition of Deutsches Arzteblatt (Dtsch Arztebl Int 2009; 106(26): 433-9). IHS include medical health services which are not reimbursed by the health insurance funds and which the patient has to pay for himself. In February 2007, the authors interviewed a total of 4898 inhabitants of LÃøbeck and Freiburg/Breisgau aged between 20 and 79 years about their experiences with limitations in health services and IHS. 1899 of the respondents were insured in an official health insurance fund and had visited a doctor during the previous 12 months. More than 20% of this group reported that there were restrictions to services - particularly when visiting orthopedic physicians, GPs and dermatologists. Most of the services refused were medicines or drugs more rarely rehabilitation measures or aids. More than 40% of the respondents reported that they had been offered IHS in the doctor"s practice or that they had enquired themselves. Most of the offers came from ophthalmologists or gynecologists. Measurements of the internal pressure in the eye and ultrasound investigations were most often suggested. The patients" enquiries were about the prescription of medicines, drugs or aids, as well as blood or laboratory tests and services related to travel medicine. The respondents had a favorable opinion about briefing concerning the costs and benefits of the additional services. There were however deficits related to the explanation of the risks, written information, written contracts on treatment and the possibility of obtaining a second opinion. Some patients said that these offers made them feel nervous, uncertain or under pressure to accept the services. About 43% of the respondents were first refused prescriptions and then offered them as IHS. / RO Deutsches Aerzteblatt


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):